Loss of expression of transforming growth factor-beta receptor as a prognostic factor in patients with renal cell carcinoma

Urology

Volumn 61, Issue 5, 2003, Pages 1072-1077

  Miyajima, Akira ^a   Asano, Tomohiko ^a   Seta, Kaori ^a   Asano, Takako ^a   Kakoi, Narihiko ^a   Hayakawa, Masamichi ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEPHRECTOMY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STATISTICAL ANALYSIS;

EID: 0038639405     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(02)02553-0     Document Type: Article

References (18)

1. Sporn M.B., Roberts A.B. Transforming growth factor-beta recent progress and new challenges . J Cell Biol. 119:1992;1017-1021.
2. Blobe G.C., Schiemann W.P., Lodish H.F. Role of transforming growth factor beta in human disease. N Engl J Med. 342:2000;1350-1358.
3. Pepper M.S. Transforming growth factor-beta vasculogenesis, angiogenesis, and vessel wall integrity . Cytokine Growth Factor Rev. 8:1997;21-43.
4. Welch D.R., Fabra A., Nakajima M. Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential. Proc Natl Acad Sci USA. 87:1990;7678-7682.
5. Wunderlich H., Steiner T., Junker U., et al. Serum transforming growth factor-beta1 in patients with renal cell carcinoma. J Urol. 157:1997;1602-1603.
6. Hojo M., Morimoto T., Maluccio M., et al. Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature. 397:1999;530-534.
7. Wrana J.L., Attisano L., Wieser R., et al. Mechanism of activation of the TGF-beta receptor. Nature. 370:1994;341-347.
8. Markowitz S., Wang J., Myeroff L., et al. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science. 268:1995;1336-1338.
9. Sun L., Wu G., Willson J.K., et al. Expression of transforming growth factor beta type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells. J Biol Chem. 269:1994;26449-26455.
10. Williams R.H., Stapleton A.M., Yang G., et al. Reduced levels of transforming growth factor beta receptor type II in human prostate cancer an immunohistochemical study . Clin Cancer Res. 2:1996;635-640.
11. Guo Y., Kyprianou N. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells. Cell Growth Differ. 9:1998;185-193.
12. Engel J.D., Kundu S.D., Yang T., et al. Transforming growth factor-beta type II receptor confers tumor suppressor activity in murine renal carcinoma (Renca) cells. Urology. 54:1999;164-170.
13. Miyajima A., Asano T., Hayakawa M. Captopril restores transforming growth factor-beta type II receptor and sensitivity to transforming growth factor-beta in murine renal cell cancer cells. J Urol. 165:2001;616-620.
14. Chang J., Park K., Bang Y.J., et al. Expression of transforming growth factor beta type II receptor reduces tumorigenicity in human gastric cancer cells. Cancer Res. 57:1997;2856-2859.
15. Kim I.Y., Ahn H.J., Lang S., et al. Loss of expression of transforming growth factor-beta receptors is associated with poor prognosis in prostate cancer patients. Clin Cancer Res. 4:1998;1625-1630.
16. Miyajima A., Chen J., Lawrence C., et al. Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstruction. Kidney Int. 58:2000;2301-2313.
17. Tokunaga H., Lee D.H., Kim I.Y., et al. Decreased expression of transforming growth factor beta receptor type I is associated with poor prognosis in bladder transitional cell carcinoma patients. Clin Cancer Res. 5:1999;2520-2525.
18. Wu G., Fan R.S., Li W., et al. Regulation of transforming growth factor-beta type II receptor expression in human breast cancer MCF-7 cells by vitamin D3 and its analogues. J Biol Chem. 273:1998;7749-7756.